Morgan Scientific has partnered with ZEPHYRx, a digital health technology innovator, to advance respiratory care.

The collaboration aims to advance respiratory care by integrating ZEPHYRx’s remote spirometry platform with Morgan Scientific’s ComPAS2 pulmonary function test (PFT) software.

This allows healthcare providers to monitor the patient’s lung functions at home.

Powered by ZEPHYRx’s respiratory cloud platform, the expanded remote spirometry offering allows real-time data collection from patients’ homes, with a live video feature for providers to guide patients through tests, ensuring accurate results.

This integration offers healthcare providers comprehensive insights into patients’ lung health by combining on-site and at-home data.

It provides historical trends, the ability to detect exacerbations, and alerts for declining lung function, allowing for quicker intervention.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

ZEPHYRx president and co-founder Michael DiCesare said: “This initiative will eliminate data disparity between point-of-care and remote lung function testing and provide a 360° view of the patient’s PFT history.”

The company’s respiratory cloud platform and the ComPAS2 PFT software from Morgan Scientific will work seamlessly together.

The software is compatible with the top 20 electronic medical records (EMRs), ensuring that home spirometry data is captured and accessible in real-time through the ZEPHYRx Provider Dashboard and the ComPAS2 system.

Morgan Scientific president Gareth Morgan said: “Our collaboration with ZEPHYRx brings together the best-in-class solutions for home spirometry data collection and enterprise-level PFT software. This solution is ideal for patients who need routine monitoring like post-lung transplant or for patients who have difficulty accessing healthcare.

“Customers are empowered to seamlessly and securely receive, review, trend, report, and access their patient’s home data in ComPAS2 and route it directly to their EMR – a truly state-of-the-art solution.”

ZEPHYRx provides decentralised respiratory monitoring solutions, offering cloud-based platforms for health systems and clinical research.